A STUDY OF EFFICACY AND SAFETY OF DRUGS USED FOR INFERTILITY AT A TERTIARY CARE CENTER-A PROSPECTIVE OBSERVATIONAL STUDY

SWETHA K.; NARESH T. PAWASKAR; AMRUTA C.; MANASA M. R.

doi:10.22159/ijpps.2025v17i2.53092

Authors

SWETHA K. Department of Pharmacology, Karwar Institute of Medical Sciences, Karwar, Karnataka, India https://orcid.org/0000-0003-2124-359X
NARESH T. PAWASKAR Department of Obg, Karwar Institute of Medical Sciences, Karwar, Karnataka, India
AMRUTA C. Department of OBG, Karwar Institute of Medical Sciences, Karwar, Karnataka, India https://orcid.org/0000-0002-6472-0571
MANASA M. R. Department of Pharmacology, Karwar Institute of Medical Sciences, Karwar, Karnataka, India https://orcid.org/0000-0003-3698-6580

DOI:

https://doi.org/10.22159/ijpps.2025v17i2.53092

Keywords:

Infertility, Clomiphene citrate, Letrozole, Efficacy, Safety

Abstract

Objective: To assess the efficacy and safety of drugs used for infertility with respect to ovulation induction and conception.

Methods: A prospective observational study was conducted in gynaecology Out Patient Department (OPD) of a tertiary care hospital from June 2019 to November 2019. 45 women who presented with history of infertility were included. Details of socio-demographic factors, treatment, investigations, efficacy and safety parameters were collected. Efficacy parameters considered were mature follicle ≥18 mm, endometrial thickness of ≥7 mm, occurrence of ovulation and pregnancy. Safety parameters included any adverse effects encountered during drug therapy.

Results: Out of 45 patients, 24 were treated with Clomiphene citrate and 21 with Letrozole. The two groups had similar baseline characteristics. Mature follicular size was attained in 83.3% of Clomiphene citrate group and 61.9% of letrozole group. Mean endometrial thickness was 7.6 mm in Clomiphene citrate while 8.3 mm in letrozole group. Ovulation occurred in 45.8% of patients in Clomiphene citrate group and 47.6% of letrozole group. 41.7% of patients in Clomiphene citrate group and 28.6% of letrozole group conceived. However, there was no significant difference between the two groups in the above parameters. No serious adverse effects were observed.

Conclusion: Both letrozole and clomiphene citrate were equally efficacious in ovulation induction and did not cause any serious adverse effects.

Downloads

Download data is not yet available.

References

Chakravorty R, Athwal A, Sur D, Saha R. A prospective randomized trial comparing the effects of letrozole versus clomiphene citrate for induction of ovulation and pregnancy rate in women with polycystic ovary syndrome. Fertil Sci Res. 2016;3(2):93-7. doi: 10.4103/fsr.fsr_10_17.

Aubuchon M, Burney RO, Schust DJ, Yao MW. Infertility and assisted reproductive technology. In: Berek JS, editor. Berek and Novak’s Gynecology. 15th ed. New Delhi: Wolters Kluwer; 2016. p. 1133-89.

Infertility National health portal of India. Available from: https://www.nhp.gov.in/disease/reproductive-system/infertility. [Last accessed on 26 Jul 2023].

Satoskar RS, Rege NN, Tripathi RK, Kamat SK. Pharmacology and pharmacotherapeutics. 26e. Bhulabhai Desai road Mumbai: Elsevier India; 2021.

Jain S, Dahiya P, Yadav J, Jain N. A comparative study of efficacy of letrozole and clomiphene citrate for ovulation induction. Int J Reprod Contracept Obstet Gynecol. 2018;7(10):4133-8. doi: 10.18203/2320-1770.ijrcog20184141.

Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril. 2006 Feb;85(2):277-84. doi: 10.1016/j.fertnstert.2005.05.078, PMID 16595197.

Brunton LL, Hilal Dandan R, Knollmann BC. Goodman and gilmans the pharmacological basis of therapeutics. 13e. New York: McGraw-Hill Education; 2018.

Kamphuis EI, Bhattacharya S, Veen F Van Der, Mol BWJ, Templeton A. Are we overusing IVF. BMJ. 2014 Jan 28;348:15-17. doi: 10.1136/bmj.g252. Available from: https://www.bmj.com/content/bmj/348/bmj.g252.full.pdf.

Tambe P, Palshetkar R, Thakkar J. FOGSI focus recent advances in infertility. Palshetkar N, Pai H, Tambe P, Dhillonpai R, Editors; 2019. p. 26-30. FOGSI. In: Available from: https://www.org/wp-content/uploads/fogsi-focus/fogsi-focusrecent-advances-infertility-2019-final-b.pdf.

Badawy A, Abdel Aal IA, Abulatta M. Retracted: clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril. 2009 Sep 1;92(3):849-52. doi: 10.1016/j.fertnstert.2007.02.062, PMID 17582406.

Maji A, Ramani MV, Kiran K. Clomiphene versus letrozole: a better agent for ovulation induction. Int J Reprod Contracept Obstet Gynecol. 2020 Sep 25;9(10):4145-9. doi: 10.18203/2320-1770.ijrcog20204303.

Ali S, Sophie R, Imam AM, Khan FI, Ali SF, Shaikh A. Knowledge perceptions and myths regarding infertility among selected adult population in Pakistan: a cross sectional study. BMC Public Health. 2011 Oct 4;11:760. doi: 10.1186/1471-2458-11-760, PMID 21970548.

Sharief M, Nafee NR. Comparison of letrazole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Pak Med Assoc. 2015 Nov;65(11):1149-52. PMID 26564281.

Palatnik A, Strawn E, Szabo A, Robb P. What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles. Fertil Steril. 2012;97(5):1089-94.e1. doi: 10.1016/j.fertnstert.2012.02.018, PMID 22459633.

Heffner LJ. Advanced maternal age how old is too old? N Engl J Med. 2004;351(19):1927-9. doi: 10.1056/NEJMp048087, PMID 15525717.

Nelson SM, Lawlor DA. Predicting live birth preterm delivery and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles. Plos Med. 2011;8(1)e1000386. doi: 10.1371/journal.pmed.1000386.

Ubaldi FM, Cimadomo D, Vaiarelli A, Fabozzi G, Venturella R, Maggiulli R. Advanced maternal age in IVF: still a challenge? The present and the future of its treatment. Front Endocrinol. 2019 Feb 20;10:94. doi: 10.3389/fendo.2019.00094, PMID 30842755.

Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853-61. doi: 10.1056/NEJM199509283331307, PMID 7651477.

Kettel LM, Roseff SJ, Berga SL, Mortola JF, Yen SS. Hypothalamic pituitary ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril. 1993;59(3):532-8. doi: 10.1016/S0015-0282(16)55795-1.

Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H. Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril. 1997;67(2):256-60. doi: 10.1016/S0015-0282(97)81907-3, PMID 9022599.

Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril. 1991;56(3):465-8. doi: 10.1016/s0015-0282(16)54541-5, PMID 1894023.

Bayar U, Tanriverdi HA, Barut A, Ayoglu F, Ozcan O, Kaya E. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil Steril. 2006;85(4):1045-8. doi: 10.1016/j.fertnstert.2005.09.045, PMID 16580393.

Revelli A, Martiny G, Delle Piane L, Benedetto C, Rinaudo P, Tur Kaspa I. A critical review of bi-dimensional and three dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome? Reprod Biol Endocrinol. 2014 Nov 24;12:107. doi: 10.1186/1477-7827-12-107, PMID 25420733.

Pandya MR, Patel K. A study of comparison of effectiveness of letrozole (5 mg) versus clomiphene citrate (100 mg) for ovulation induction among infertile women. Indian J Obstet Gynecol Res. 2021;8(4):553-8. doi: 10.18231/j.ijogr.2021.113.

Nazmashamim N, KL, Basavaradder V. Clomiphene citrate vs letrozole for ovulation induction in subfertile women with polycystic ovary syndrome: a randomized controlled trial. New Indian J OBGYN. 2022;9(1):26-30. doi: 10.21276/obgyn.2022.9.1.6.

Al Shoraky Mohamed S, El Din Hussien H, Ahmed El Desouky ES. Letrozole versus clomiphene citrate for ovulation induction in women with polycystic ovary syndrome. Al Azhar Medical Journal. 2020;49(1):209-18. doi: 10.21608/amj.2020.67551.

Oliveira JB, Baruffi RL, Mauri AL, Petersen CG, Borges MC, Franco JG. Endometrial ultrasonography as a predictor of pregnancy in an in vitro fertilization programme after ovarian stimulation and gonadotrophin releasing hormone and gonadotrophins. Hum Reprod. 1997;12(11):2515-8. doi: 10.1093/humrep/12.11.2515, PMID 9436697.

Ghomian N, Khosravi A, Mousavifar N. A randomized clinical trial on comparing the cycle characteristics of two different initiation days of letrozole treatment in clomiphene citrate resistant PCOS patients in IUI cycles. Int J Fertil Steril. 2015;9(1):17-26. doi: 10.22074/ijfs.2015.4204, PMID 25918588.

Khan S, Rao P, Kushwaha S. A comparative study of letrozole versus clomiphene citrate in ovulation induction in patients with the polycystic ovarian syndrome. Int J Med Sci Clin Res Rev. 2022 Sep;305(5):682-7.

Franks S, Adams J, Mason H, Polson D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol. 1985;12(3):605-32. doi: 10.1016/s0306-3356(21)00138-2, PMID 3933879.